Glenmark Pharmaceuticals Q3 PAT seen up 17.8% YoY to Rs 292.4 cr: Prabhudas Lilladher Net Sales are expected to increase by 10.3 percent Y-o-Y (down 2.4 percent Q-o-Q) to Rs 3,073.1 crore, according to Prabhudas Lilladher.